@article{TCR26599,
author = {Stéphane Supiot and Caroline Rousseau},
title = {Oligometastatic prostate cancer: is it worth targeting the tip of the iceberg?},
journal = {Translational Cancer Research},
volume = {8},
number = {Suppl 2},
year = {2019},
keywords = {},
abstract = {Until recently, the only routinely available imaging techniques of prostate cancer were computed tomography (CT) scan ± contrast, magnetic resonance imaging (MRI) and a standard bone scan. The increasing use of modern imaging techniques such as positron emission tomography-computed tomography (PET-CT) with tumour-specific radiotracers [Choline, Fluciclovine or prostate-specific membrane antigen (PSMA) ligand], and, increasingly, whole-body MRI with diffusion-weighted imaging (WB MRI-DWI), means that oligometastases in prostate cancer are commonly discovered before any radical treatment or once the prostate specific antigen (PSA) has risen following radical treatment.},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/26599}
}